Medical Imaging Devices: Global Regulation & Registration

For every regulator below we answer the three questions imaging device teams ask first: what class is my scanner, how long will it take, and what will it cost. Our pricing calculator puts government fees and honest timelines next to every figure on this page.

What are medical imaging devices?

Medical imaging is the use of X-rays, magnetic fields, sound waves, and radiotracers to picture the inside of the body; medical imaging devices are the hardware systems that produce those pictures for diagnosis, screening, or treatment guidance. The four modalities most people mean by medical imaging are X-ray-based systems (radiography, fluoroscopy, mammography, and computed tomography), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine imaging (PET and SPECT). Everyday examples are a CT scanner, an MRI machine, an ultrasound system, a diagnostic X-ray unit, a mammography system, and a C-arm in the operating room. This category is about that physical medical imaging equipment — the diagnostic imaging devices themselves — not the administrative software or the archiving systems that store the images.

The catch is that every jurisdiction draws the classification line differently, and it moves with the physics. A non-ionizing ultrasound or MRI system usually sits a class below an X-ray or CT system that emits ionizing radiation, and a device that only displays images is regulated differently from one that drives a diagnostic decision. Every cost below has two parts: the government fee, and our own flat annual service fee per market, from US$1,000 per year in the US (device listing and US Agent representation) and from US$2,000 per year in most other markets. Exact current figures live in our pricing calculator.

Imaging hardware vs. AI imaging software

Keep two things separate. This page covers imaging hardware: the scanner and its embedded control software as one product. The algorithms that read the resulting images, such as AI that detects or triages findings, computer-aided detection (CADe), and computer-aided diagnosis (CADx), are usually standalone software as a medical device and follow their own classification and submission path. If your product is the analysis software rather than the scanner, start from our software as a medical device page; if it is the imaging system itself, stay here.

FDA medical imaging device regulation (United States)

FDA regulates imaging hardware through the same risk-based device framework as other equipment, with a radiological-health layer on top: systems that emit ionizing radiation, such as diagnostic X-ray and CT, also meet FDA's electronic product radiation performance standards (21 CFR 1020) alongside their clearance, including certification and a radiation-safety product report to CDRH under 21 CFR 1002 before marketing.

• Classification. Most imaging hardware, including CT, MRI, ultrasound, and diagnostic X-ray systems, is Class II and clears through a 510(k) against a predicate device. As Class II devices they clear under general and special controls — for imaging, chiefly conformance with FDA-recognized performance standards and device-specific guidance. A genuinely novel imaging system with no predicate goes the De Novo route; the classification and predicate analysis is the first deliverable.
• Timeline. A 510(k) typically runs 3 to 9 months end to end including preparation and FDA interaction; a De Novo plans for 9 to 15 months. A Pre-Submission meeting adds a few weeks up front and routinely saves review cycles later.
• Cost. Government fees (FY2026 MDUFA): US$26,067 for a standard 510(k) review (US$6,517 for qualified small businesses) plus US$11,423 per year in establishment registration. Our flat US$1,000 per year covers FDA establishment registration and device listing maintenance plus US Agent representation; 510(k) preparation and submission are scoped as a separate project.

Start from our United States market page for the full FDA pathway.

EU MDR medical imaging device classification and CE marking

Under the EU Medical Device Regulation, imaging systems are active devices intended for diagnosis, and Rule 10 sets the class. A notified body sits in the middle of your timeline for every class above I.

• Classification. Rule 10 places active diagnostic devices at Class IIa in general; systems that emit ionizing radiation, or that control, monitor, or directly influence such a system (X-ray, CT, fluoroscopy, and mammography) move up to Class IIb. Non-ionizing MRI and ultrasound systems generally stay Class IIa.
• Timeline. Plan 9 to 18 months with a notified body for a first IIa or IIb certification, driven by notified body capacity and the maturity of your technical documentation and clinical evaluation under MDR Annex XIV.
• Cost. There is no central government fee; the money goes to the notified body, typically €30,000 to €70,000 across a first Class IIa certification cycle, more for higher classes, plus annual surveillance, and to building MDR-grade documentation. Our EU Authorized Representative service is a flat annual fee from US$2,000, capped at US$4,000 as your portfolio grows, and covers EC REP representation, document review, and EUDAMED support; CE-marking work with your notified body is scoped separately.

See the European Union market page for the MDR route and notified body strategy.

Medical imaging device registration in Brazil and Latin America (ANVISA)

Brazil anchors any Latin American strategy, and ANVISA classifies medical devices under RDC 751/2022 on the IMDRF model; Mexico's COFEPRIS is the region's second gate. Both require a local representative, and we act as Brazil Registration Holder without taking control of your registration.

• Classification. Lower-risk imaging hardware qualifies for the streamlined notificação route, while higher-risk or higher-class configurations require full registro with deeper technical evidence.
• Timeline. Notification is typically a matter of weeks; a higher-class registro plans for 6 to 12 months. In Mexico, COFEPRIS runs 6 to 12 months on the standard route, and faster where reliance on an FDA or CE approval applies.
• Cost. ANVISA government fees: R$1,406 to notify a Class I-II product; Class III-IV family registration runs R$8,510 to R$19,856, plus a one-time international B-GMP certification of R$72,805 where required. COFEPRIS charges MX$16,499 to MX$30,798 per product by class. Our registration service starts at US$2,000 per year (US$3,000 for high-risk classes) in both markets.

Start with the Brazil market page; labeling and instructions for use are prepared natively in Portuguese and Spanish.

Medical imaging device registration in Asia-Pacific: Singapore first, then ASEAN

Most overseas imaging manufacturers enter Asia-Pacific through Singapore: HSA works in English, follows the IMDRF model, and rewards a good FDA or CE dossier with a fast abridged review. A Singapore approval then anchors expansion across ASEAN (Malaysia, Thailand, Indonesia, Vietnam, and the Philippines), where reliance-friendly frameworks make each additional market incremental rather than a new program. Japan and Korea are the region's big mature prizes with their own systems and languages. China is the largest market but the hardest entry, with local type testing and the longest timelines, so treat it as its own program when the business case justifies it, not as a default stop.

• Classification. Singapore's HSA uses risk classes A through D, and ASEAN members track the same IMDRF-style model under the ASEAN Medical Device Directive. Japan classifies against JMDN codes; Korea's MFDS uses Classes I-IV; China's NMPA manages CT, MRI, PET/SPECT, and angiography/DSA systems as Class III under its classification catalogue, with diagnostic ultrasound, general radiography X-ray, and plain C-arms typically Class II.
• Timeline. HSA abridged evaluation with a reference approval closes in 2 to 6 months; ASEAN registrations typically run 3 to 9 months per market on the back of the same dossier. Japan plans for 9 to 14 months via PMDA (certification routes for lower classes are faster); Korea 6 to 12 months including KGMP; China 12 to 24 months including type testing.
• Cost. Singapore's fees are light: a SGD 560 application plus SGD 2,010 to SGD 6,250 evaluation by class; Malaysia charges MYR 500 to apply plus MYR 750 to MYR 3,000 to register; Thailand runs THB 3,100 to THB 21,000 by class, with a THB 53,000 expert review where required. Japan's PMDA review fees start around ¥1 million; China's NMPA fees for imported Class II-III run roughly RMB 210,000 to RMB 310,000 before type testing. Our registration service starts at US$2,000 per year across Singapore and ASEAN.

One well-built reference dossier does most of the region's work. See the Singapore, Malaysia, Thailand, Japan, South Korea, and China market pages.

Medical imaging device registration in Saudi Arabia and MENA (SFDA)

The Gulf's regulators are built around reliance: a strong FDA, CE, or other reference approval does most of the work if the dossier is assembled correctly. SFDA regulates imaging devices on the IMDRF model and requires a local Authorized Representative.

• Classification. SFDA classifies devices into risk classes A through D, mirroring your reference-market class in most cases; the UAE's MOHAP and other MENA authorities lean on the reference approval's classification.
• Timeline. With a reference approval in hand, SFDA marketing authorization typically closes in 2 to 6 months, and UAE registration runs a similar range. Without a reference approval, expect materially longer.
• Cost. Government fees across the Gulf are modest, generally a few thousand US dollars' equivalent per authority, so the real spend is dossier assembly, Arabic labeling where required, and local representation. We quote MENA registration programs flat per market, on the same transparent model as our calculator markets.

See the Saudi Arabia and UAE market pages.

Evidence, quality system, and lifecycle

For imaging hardware the evidence center of gravity is bench and safety testing, not large clinical trials. Every major market expects IEC 60601-1 electrical safety and IEC 60601-1-2 electromagnetic compatibility testing, plus the modality's collateral and particular standards: acoustic output limits for ultrasound set by FDA's Marketing Clearance of Diagnostic Ultrasound Systems and Transducers guidance, dose and image-quality requirements for CT and X-ray, MR safety testing under IEC 60601-2-33 (SAR, gradient output, and acoustic noise limits) for MRI — with MR Safe/MR Conditional labeling per ASTM F2503 for coils and accessories that enter the magnet room — and DICOM conformance so the system interoperates with hospital PACS. We set up an ISO 13485 quality system, plan this testing once so a single campaign supports FDA, EU MDR, and Asia-Pacific submissions, and prepare the performance and, where needed, clinical evaluation each regulator expects. Because modern diagnostic imaging equipment is networked and software-driven, we also maintain cybersecurity documentation that satisfies FDA, EU MDR, and IEC 81001-5-1. After launch, change assessments, complaint handling, and vigilance keep every registration current.

One program, every major market

A global imaging program is a sequencing problem: pick the anchor market, run the safety and performance test campaign once, and reuse the dossier, classification analyses, and QMS artifacts everywhere else. We run the full program from a single team, covering strategy, submissions, in-country representation, and post-market maintenance, with transparent government fees and timelines in our pricing calculator.